Researchers tested the cells of more than 1,000 individuals with different genetic backgrounds for sensitivity to 179 therapeutic and industrial chemical compounds.
A financial analysis in Science Translational Medicine finds that two NCATS rare diseases programs have led to reduced cost of developing new drugs and reduced financial risks.
CTSA hubs are forming a national network to overcome barriers to participant recruitment for clinical trials.
ExRNA communication researchers find saliva provides a strong foundation for a noninvasive diagnostic test for stomach cancer.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
NIH research team works with industry to develop treatments for lysosomal storage disorders.
Research team identifies 50+ drugs that may block Ebola infection.
- Use of Updated Inclusion Enrollment Format Now Required for Successful Submission of RPPR
- Notice of NCATS' Participation in RFA-CA-15-006 "Big Data to Knowledge Advancing Biomedical Science Using Crowdsourcing and Interactive Digital Media
- Notice of NIH Participation in the Cyber-Physical Systems Initiative (CPS)
- More Funding & Notices...
IN THE SPOTLIGHT
NCATS intends to publish funding opportunities for Collaborative Innovation Awards through the Clinical and Translational Science Awards program. See the notices below for details: